CGN Advisors’s Bruker BRKR Stock Holding History

CGN Advisors’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,014	Closed	-$919K	–	297
2025 Q1	$919K	Buy	22,014 +296	+1%	+$15.4K	0.09%	175
2024 Q4	$1.27M	Buy	+21,718	New	+$1.28M	0.12%	152

Other funds holding BRKR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

CGN Advisors's BRKR Position: Q2 2025 in Review

CGN Advisors sold out of Bruker (BRKR) in Q2 2025, closing a stake of 22,014 shares — an estimated $919K sold.

CGN Advisors first reported a position in BRKR in Q4 2024 and held it in 2 quarters. The position peaked at $1.27M in Q4 2024. 370 funds tracked by Wall St. Rank hold BRKR as of Q2 2025.

CGN Advisors reported no remaining Bruker position as of Q2 2025 after selling out during the quarter.
CGN Advisors sold 22,014 Bruker shares in Q2 2025, an estimated $919K.
CGN Advisors first reported a position in Bruker in Q4 2024 and held it in 2 quarters.
CGN Advisors's Bruker position peaked at $1.27M in Q4 2024.
370 funds tracked by Wall St. Rank held Bruker as of Q2 2025.

Based on CGN Advisors's 13F filing for Q2 2025, filed 15 Jul 2025.